First Hawaiian Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Hold
4,435
0.03% 79
2026
Q1
$269K Hold
4,435
0.04% 76
2025
Q4
$239K Hold
4,435
0.03% 82
2025
Q3
$200K Hold
4,435
0.03% 95
2025
Q2
$205K Buy
4,435
+174
+4% +$8.54K 0.03% 95
2025
Q1
$260K Sell
4,261
-45,937
-92% -$2.68M 0.04% 79
2024
Q4
$2.84M Buy
50,198
+1,675
+3% +$93.6K 0.09% 155
2024
Q3
$2.51M Buy
48,523
+951
+2% +$44.6K 0.08% 178
2024
Q2
$1.98M Sell
47,572
-15,459
-25% -$692K 0.07% 224
2024
Q1
$3.42M Sell
63,031
-14,933
-19% -$761K 0.11% 137
2023
Q4
$4M Buy
77,964
+297
+0.4% +$15.6K 0.13% 105
2023
Q3
$4.51M Sell
77,667
-17
-0% -$1.04K 0.15% 78
2023
Q2
$4.97M Buy
77,684
+9,415
+14% +$631K 0.16% 70
2023
Q1
$4.73M Sell
68,269
-669
-1% -$47.2K 0.16% 71
2022
Q4
$4.96M Buy
68,938
+2,884
+4% +$217K 0.18% 64
2022
Q3
$4.7M Buy
66,054
+1,115
+2% +$80.9K 0.18% 63
2022
Q2
$5M Sell
64,939
-18,928
-23% -$1.44M 0.18% 64
2022
Q1
$6.13M Sell
83,867
-1,214
-1% -$81.5K 0.19% 60
2021
Q4
$5.3M Buy
85,081
+32,008
+60% +$1.88M 0.16% 81
2021
Q3
$3.14M Buy
53,073
+2,438
+5% +$161K 0.13% 98
2021
Q2
$3.38M Sell
50,635
-6,860
-12% -$447K 0.14% 87
2021
Q1
$3.63M Sell
57,495
-1,109
-2% -$69K 0.16% 83
2020
Q4
$3.63M Buy
58,604
+931
+2% +$57.2K 0.17% 81
2020
Q3
$3.48M Sell
57,673
-19,506
-25% -$1.17M 0.18% 75
2020
Q2
$4.54M Buy
77,179
+18,543
+32% +$1.11M 0.24% 58
2020
Q1
$3.27M Buy
58,636
+9,847
+20% +$602K 0.2% 70
2019
Q4
$3.13M Buy
48,789
+12,611
+35% +$722K 0.15% 92
2019
Q3
$1.83M Buy
36,178
+5,720
+19% +$269K 0.09% 156
2019
Q2
$1.38M Buy
30,458
+927
+3% +$43.2K 0.07% 196
2019
Q1
$1.41M Sell
29,531
-5,388
-15% -$268K 0.08% 189
2018
Q4
$1.82M Buy
34,919
+4,984
+17% +$268K 0.11% 132
2018
Q3
$1.86M Buy
29,935
+23,873
+394% +$1.42M 0.1% 148
2018
Q2
$335K Sell
6,062
-232
-4% -$12.5K 0.04% 71
2018
Q1
$398K Buy
6,294
+955
+18% +$61.4K 0.05% 70
2017
Q4
$327K Sell
5,339
-37
-0.7% -$2.31K 0.04% 79
2017
Q3
$344K Sell
5,376
-907
-14% -$53K 0.05% 72
2017
Q2
$350K Buy
6,283
+330
+6% +$18K 0.05% 66
2017
Q1
$324K Sell
5,953
-21
-0.4% -$1.15K 0.05% 66
2016
Q4
$350K Buy
5,974
+878
+17% +$48K 0.06% 63
2016
Q3
$275K Sell
5,096
-1,766
-26% -$113K 0.05% 67
2016
Q2
$505K Buy
6,862
+83
+1% +$5.87K 0.09% 51
2016
Q1
$432K Buy
6,779
+450
+7% +$28.4K 0.07% 59
2015
Q4
$436K Sell
6,329
-53
-0.8% -$3.5K 0.07% 59
2015
Q3
$378K Sell
6,382
-450
-7% -$28.5K 0.07% 58
2015
Q2
$454K Sell
6,832
-235
-3% -$15.5K 0.07% 55
2015
Q1
$455K Buy
7,067
+7
+0.1% +$438 0.07% 54
2014
Q4
$417K Sell
7,060
-860
-11% -$48.5K 0.07% 102
2014
Q3
$406K Sell
7,920
-3,120
-28% -$156K 0.07% 101
2014
Q2
$536K Buy
11,040
+218
+2% +$10.7K 0.09% 64
2014
Q1
$562K Sell
10,822
-5,134
-32% -$273K 0.1% 54
2013
Q4
$849K Sell
15,956
-2,472
-13% -$126K 0.15% 41
2013
Q3
$853K Buy
18,428
+5,990
+48% +$263K 0.17% 39
2013
Q2
$556K Buy
+12,438
New +$540K 0.11% 58

Other funds holding BMY

First Hawaiian Bank's BMY Position: Q2 2026 in Review

First Hawaiian Bank held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 4,435 shares worth $256K. The position accounts for 0.03% of the portfolio, ranked #79.

First Hawaiian Bank first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.13M in Q1 2022. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • First Hawaiian Bank held 4,435 shares of Bristol-Myers Squibb worth $256K as of Q2 2026.
  • First Hawaiian Bank left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.03% of First Hawaiian Bank's portfolio in Q2 2026, its #79 holding.
  • First Hawaiian Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • First Hawaiian Bank's Bristol-Myers Squibb position peaked at $6.13M in Q1 2022.
  • 832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on First Hawaiian Bank's 13F filing for Q2 2026, filed 13 Jul 2026.